前立腺ヘルスの世界市場レポート 2025

前立腺ヘルス市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.3％で532億5,000万米ドルに成長します。予測期間の成長は、精密医療の採用拡大、AI主導型診断の利用拡大、標的化放射線治療の拡大、低侵襲治療に対する需要の高まり、リスク評価のための遺伝子プロファイリングの改善に起因すると考えられます。この期間に予想される主な動向には、AIを活用したリスク評価、リキッドバイオプシーの進歩、次世代放射線治療、免疫療法の革新、リアルタイムのバイオマーカー・モニタリングなどがあります。

前立腺がんの有病率の増加は、前立腺ヘルス市場の成長を促進すると予想されます。前立腺がんは、前立腺の細胞が制御不能に増殖することで発生し、男性では腺がんが最も一般的です。前立腺がん患者の増加は、主に高齢化、検診の増加、肥満や運動不足などのライフスタイル要因に起因しています。前立腺ヘルスを維持することは、前立腺がんの予防、発見、管理に極めて重要です。例えば、2023年1月、米国の非営利団体である米国がん協会（ACS）は、2023年に米国で新たに前立腺がんと診断される患者数は約28万8,300人、死亡者数は3万4,700人と推定しています。その結果、前立腺がんの有病率の増加が前立腺ヘルス市場の拡大に拍車をかけています。

前立腺ヘルス市場の主要企業は、AIを活用したリスク評価などの技術的進歩を活用して診断精度を高め、不要な生検を減らしています。AIを活用したリスク評価は、人工知能アルゴリズムを活用してデータを分析し、潜在的なリスクを予測し、患者の転帰を改善するための情報に基づいた意思決定をサポートします。例えば、2024年9月、カナダを拠点とする臨床段階のバイオテクノロジー企業であるナノスティックス・インクは、米国を拠点とするバイオテクノロジー企業であるプロテアン・バイオダイアグノスティックスと提携し、侵攻性前立腺がんのリスクを抱える男性向けに設計された診断ツールであるCDX Prostateを発売しました。このツールは、生物学的データ、臨床情報、AIを活用した学習モデルを統合してリスクスコアを生成し、従来の方法と比較してより正確な評価を提供します。CDX Prostateは、前立腺特異抗原（PSA）検査の高値や直腸指診（DRE）の異常の後、生検を行うかどうかの判断をヘルスケアプロバイダーと患者に支援します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界前立腺ヘルス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の前立腺ヘルス市場：成長率分析
• 世界の前立腺ヘルス市場の実績：規模と成長, 2019-2024
• 世界の前立腺ヘルス市場の予測：規模と成長, 2024-2029, 2034F
• 世界前立腺ヘルス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の前立腺ヘルス市場：疾患適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 前立腺がん
• 良性前立腺肥大症
• 前立腺炎
• 世界の前立腺ヘルス市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホルモン療法
• 化学療法
• 外科的治療
• その他の治療法
• 世界の前立腺ヘルス市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• Eコマースストア
• 薬局
• その他の流通チャネル
• 世界の前立腺ヘルス市場前立腺がんの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所性前立腺がん
• 転移性前立腺がん
• 世界の前立腺ヘルス市場良性前立腺肥大症の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 軽度のBPH
• 中等度のBPH
• 重度のBPH
• 世界の前立腺ヘルス市場前立腺炎の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性細菌性前立腺炎
• 慢性細菌性前立腺炎
• 慢性前立腺炎（非細菌性）

第7章 地域別・国別分析

• 世界の前立腺ヘルス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の前立腺ヘルス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 前立腺ヘルス市場：競合情勢
• 前立腺ヘルス市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AstraZeneca PLC
• Abbott Laboratories
• Novartis AG
• Takeda Pharmaceutical Co Ltd
• Astellas Pharma Inc
• Genentech Inc.
• Teleflex Inc.
• Elekta AB
• Myriad Genetics Inc.
• Freenome
• Theragenics Corporation
• CureVac BV
• ArsenalBio
• Roivant Sciences
• Artera Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 前立腺ヘルス市場2029：新たな機会を提供する国
• 前立腺ヘルス市場2029：新たな機会を提供するセグメント
• 前立腺ヘルス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Prostate health encompasses the overall well-being and proper functioning of the prostate gland, a small organ in men responsible for producing seminal fluid. Maintaining prostate health is crucial for urinary function, reproductive health, and the prevention of conditions such as prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer. Factors affecting prostate health include age, genetics, diet, lifestyle, and regular medical screenings.

The primary disease indications related to prostate health include prostate cancer, benign prostatic hyperplasia, and prostatitis. Prostate cancer originates in the prostate gland and is characterized by the uncontrolled growth of prostate cells, potentially leading to tumor formation and metastasis. Treatment options include hormonal therapy, chemotherapy, surgical procedures, and other approaches. Various distribution channels for prostate health treatments include e-commerce stores, pharmacies, and other outlets.

The prostate health market research report is one of a series of new reports from The Business Research Company that provides prostate health market statistics, including prostate health industry global market size, regional shares, competitors with a prostate health market share, detailed prostate health market segments, market trends and opportunities, and any further data you may need to thrive in the prostate health industry. This prostate health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prostate health market size has grown strongly in recent years. It will grow from $34.07 billion in 2024 to $37.34 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth during the historic period can be attributed to an aging population, increased PSA screening, rising awareness campaigns, advancements in hormone therapy, and growing incidence rates.

The prostate health market size is expected to see strong growth in the next few years. It will grow to $53.25 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to the growing adoption of precision medicine, increasing use of AI-driven diagnostics, the expansion of targeted radiotherapies, rising demand for minimally invasive treatments, and improved genetic profiling for risk assessment. Key trends expected during this period include AI-powered risk assessment, advancements in liquid biopsy, next-generation radiotheranostics, innovations in immunotherapy, and real-time biomarker monitoring.

The increasing prevalence of prostate cancer is expected to drive the growth of the prostate health market. Prostate cancer occurs when cells in the prostate gland grow uncontrollably, with adenocarcinomas being the most common form in men. The rise in prostate cancer cases is primarily attributed to an aging population, increased screening practices, and lifestyle factors such as obesity and physical inactivity. Maintaining prostate health is crucial for preventing, detecting, and managing prostate cancer. For example, in January 2023, the American Cancer Society (ACS), a US-based nonprofit organization, projected approximately 288,300 new prostate cancer diagnoses in the U.S. in 2023, with an estimated 34,700 fatalities. As a result, the growing prevalence of prostate cancer is fueling the expansion of the prostate health market.

Leading companies in the prostate health market are leveraging technological advancements such as AI-powered risk assessment to enhance diagnostic accuracy and reduce unnecessary biopsies. AI-powered risk assessment utilizes artificial intelligence algorithms to analyze data, predict potential risks, and support informed decision-making for improved patient outcomes. For instance, in September 2024, Nanostics Inc., a Canada-based clinical-stage biotechnology company, partnered with Protean BioDiagnostics, a US-based biotechnology company, to launch CDX Prostate, a diagnostic tool designed for men at risk of aggressive prostate cancer. This tool integrates biological data, clinical information, and AI-powered learning models to generate a risk score, offering a more precise assessment compared to traditional methods. CDX Prostate assists healthcare providers and patients in determining whether to proceed with a biopsy following a high prostate-specific antigen (PSA) test result or an abnormal digital rectal exam (DRE).

In June 2024, Lantheus Holdings Inc., a US-based radiopharmaceutical company, acquired worldwide rights to Life Molecular Imaging's RM2 for an undisclosed amount. This acquisition aims to strengthen Lantheus' presence in prostate cancer treatment while expanding its pipeline to include breast and other cancers. RM2 is a novel radiotheranostic pair, including 177Lu-DOTA-RM2 and 68Ga-DOTA-RM2, which target the gastrin-releasing peptide receptor (GRPR). Life Molecular Imaging, a Germany-based radiopharmaceutical company, specializes in developing innovative radiopharmaceuticals to enhance early detection and diagnosis of chronic and life-threatening conditions.

Major players in the prostate health market are Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Bayer AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc, Genentech Inc., Teleflex Inc., Elekta AB, Myriad Genetics Inc., Freenome, Theragenics Corporation, CureVac BV, ArsenalBio, Roivant Sciences, Artera Inc., Veru Inc., HistoSonics Inc., Immunic Inc., Ezra, Francis Medical, CorTechs Labs, Lucida Medical, Serimmune Inc., and Alessa Therapeutics.

North America was the largest region in the prostate health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in prostate health report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the prostate health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prostate health market includes revenues earned by entities providing services such as diagnostic screening, medical consultations, prostate cancer treatments, minimally invasive procedures for benign prostatic hyperplasia (BPH), telemedicine consultations, and wellness programs focused on prostate health. Only goods and services traded between entities or sold to end consumers are included. The prostate health market consists of sales of pharmaceuticals, medical devices, dietary supplements, and diagnostic kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prostate Health Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prostate health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prostate health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prostate health market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Indication: Prostate Cancer, Benign Prostate Hyperplasia, Prostatitis
• 2) By Treatment: Hormonal Therapy, Chemotherapy, Surgical Treatments, Other Treatments
• 3) By Distribution Channel: E-Commerce Stores, Pharmacies, Other Distribution Channels
• Subsegments:
• 1) By Prostate Cancer: Localized Prostate Cancer; Metastatic Prostate Cancer
• 2) By Benign Prostate Hyperplasia: Mild BPH; Moderate BPH; Severe BPH
• 3) By Prostatitis: Acute Bacterial Prostatitis; Chronic Bacterial Prostatitis; Chronic Prostatitis (Non-Bacterial)
• Companies Mentioned:Pfizer Inc.; Johnson & Johnson; Siemens Healthineers AG; Bayer AG; Sanofi SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prostate Health Market Characteristics

3. Prostate Health Market Trends And Strategies

4. Prostate Health Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Prostate Health Growth Analysis And Strategic Analysis Framework

• 5.1. Global Prostate Health PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Prostate Health Market Growth Rate Analysis
• 5.4. Global Prostate Health Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Prostate Health Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Prostate Health Total Addressable Market (TAM)

6. Prostate Health Market Segmentation

• 6.1. Global Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prostate Cancer
• Benign Prostate Hyperplasia
• Prostatitis
• 6.2. Global Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormonal Therapy
• Chemotherapy
• Surgical Treatments
• Other Treatments
• 6.3. Global Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• E-Commerce Stores
• Pharmacies
• Other Distribution Channels
• 6.4. Global Prostate Health Market, Sub-Segmentation Of Prostate Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Localized Prostate Cancer
• Metastatic Prostate Cancer
• 6.5. Global Prostate Health Market, Sub-Segmentation Of Benign Prostate Hyperplasia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mild BPH
• Moderate BPH
• Severe BPH
• 6.6. Global Prostate Health Market, Sub-Segmentation Of Prostatitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Bacterial Prostatitis
• Chronic Bacterial Prostatitis
• Chronic Prostatitis (Non-Bacterial)

7. Prostate Health Market Regional And Country Analysis

• 7.1. Global Prostate Health Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Prostate Health Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prostate Health Market

• 8.1. Asia-Pacific Prostate Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prostate Health Market

• 9.1. China Prostate Health Market Overview
• 9.2. China Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prostate Health Market

• 10.1. India Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prostate Health Market

• 11.1. Japan Prostate Health Market Overview
• 11.2. Japan Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prostate Health Market

• 12.1. Australia Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prostate Health Market

• 13.1. Indonesia Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prostate Health Market

• 14.1. South Korea Prostate Health Market Overview
• 14.2. South Korea Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prostate Health Market

• 15.1. Western Europe Prostate Health Market Overview
• 15.2. Western Europe Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prostate Health Market

• 16.1. UK Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prostate Health Market

• 17.1. Germany Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prostate Health Market

• 18.1. France Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prostate Health Market

• 19.1. Italy Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prostate Health Market

• 20.1. Spain Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prostate Health Market

• 21.1. Eastern Europe Prostate Health Market Overview
• 21.2. Eastern Europe Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prostate Health Market

• 22.1. Russia Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prostate Health Market

• 23.1. North America Prostate Health Market Overview
• 23.2. North America Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prostate Health Market

• 24.1. USA Prostate Health Market Overview
• 24.2. USA Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prostate Health Market

• 25.1. Canada Prostate Health Market Overview
• 25.2. Canada Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prostate Health Market

• 26.1. South America Prostate Health Market Overview
• 26.2. South America Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prostate Health Market

• 27.1. Brazil Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prostate Health Market

• 28.1. Middle East Prostate Health Market Overview
• 28.2. Middle East Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prostate Health Market

• 29.1. Africa Prostate Health Market Overview
• 29.2. Africa Prostate Health Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Prostate Health Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Prostate Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prostate Health Market Competitive Landscape And Company Profiles

• 30.1. Prostate Health Market Competitive Landscape
• 30.2. Prostate Health Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Prostate Health Market Other Major And Innovative Companies

• 31.1. AstraZeneca PLC
• 31.2. Abbott Laboratories
• 31.3. Novartis AG
• 31.4. Takeda Pharmaceutical Co Ltd
• 31.5. Astellas Pharma Inc
• 31.6. Genentech Inc.
• 31.7. Teleflex Inc.
• 31.8. Elekta AB
• 31.9. Myriad Genetics Inc.
• 31.10. Freenome
• 31.11. Theragenics Corporation
• 31.12. CureVac BV
• 31.13. ArsenalBio
• 31.14. Roivant Sciences
• 31.15. Artera Inc.

32. Global Prostate Health Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prostate Health Market

34. Recent Developments In The Prostate Health Market

35. Prostate Health Market High Potential Countries, Segments and Strategies

• 35.1 Prostate Health Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Prostate Health Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Prostate Health Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer